Interfering peptides targeting protein-protein interactions: the next generation of drugs?

被引:106
作者
Bruzzoni-Giovanelli, Heriberto [1 ,2 ,3 ]
Alezra, Valerie [4 ]
Wolff, Nicolas [5 ]
Dong, Chang-Zhi [1 ,6 ]
Tuffery, Pierre [1 ,7 ]
Rebollo, Angelita [8 ]
机构
[1] Univ Sorbonne Paris Cite, Univ Paris 7 Denis Diderot, Paris, France
[2] INSERM, UMRS 1160, Paris, France
[3] Hop St Louis, AP HP, INSERM, Ctr Invest Clin 1427, Paris, France
[4] Univ Paris Saclay, Univ Paris Sud, CNRS,Fac Sci Orsay, Lab Methodol Synth & Mol Therape,ICMMO,UMR 8182, Paris, France
[5] CNRS, Inst Pasteur, Unite Resonance Magnet Nucl Biomol, UMR 3528, F-75015 Paris, France
[6] CNRS, ITODYS, UMR 7086, Paris, France
[7] INSERM, UMR S 973, RPBS, Paris, France
[8] UPMC, INSERM, Hop Pitie Salpetriere, CIMI Paris,U1135, Paris, France
关键词
CELL-PENETRATING PEPTIDES; STRUCTURE-BASED DESIGN; IN-VIVO; STAPLED PEPTIDES; CYCLIC-PEPTIDES; BINDING-SITES; CONSTRAINED PEPTIDES; MACROCYCLIC PEPTIDES; STRUCTURE PREDICTION; CELLULOSE MEMBRANES;
D O I
10.1016/j.drudis.2017.10.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Protein-protein interactions (PPIs) are well recognized as promising therapeutic targets. Consequently, interfering peptides (IPs) - natural or synthetic peptides capable of interfering with PPIs - are receiving increasing attention. Given their physicochemical characteristics, IPs seem better suited than small molecules to interfere with the large surfaces implicated in PPIs. Progress on peptide administration, stability, biodelivery and safety are also encouraging the interest in peptide drug development. The concept of IPs has been validated for several PPIs, generating great expectations for their therapeutic potential. Here, we describe approaches and methods useful for IPs identification and in silico, physicochemical and biological-based strategies for their design and optimization. Selected promising in-vivo-validated examples are described and advantages, limitations and potential of IPs as therapeutic tools are discussed.
引用
收藏
页码:272 / 285
页数:14
相关论文
共 172 条
[41]   Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment [J].
Ellert-Miklaszewska, Aleksandra ;
Poleszak, Katarzyna ;
Kaminska, Bozena .
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (02) :199-221
[42]   Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery [J].
Eustache, Stephanie ;
Leprince, Jerome ;
Tuffery, Pierre .
EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (08) :771-784
[43]   Peptide, peptidomimetic, and small-molecule antagonists of the p53-HDM2 protein-protein interaction [J].
Fischer, PM .
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2006, 12 (01) :3-19
[44]   Fusion to Snowdrop Lectin Magnifies the Oral Activity of Insecticidal ω-Hexatoxin-Hv1a Peptide by Enabling Its Delivery to the Central Nervous System [J].
Fitches, Elaine C. ;
Pyati, Prashant ;
King, Glenn F. ;
Gatehouse, John A. .
PLOS ONE, 2012, 7 (06)
[45]   Targeting protein-protein interactions by rational design: mimicry of protein surfaces [J].
Fletcher, Steven ;
Hamilton, Andrew D. .
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2006, 3 (07) :215-233
[46]   Unintended Consequences of Expensive Cancer Therapeutics-The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity The John Conley Lecture [J].
Fojo, Tito ;
Mailankody, Sham ;
Lo, Andrew .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (12) :1225-1236
[47]   Peptide therapeutics: current status and future directions [J].
Fosgerau, Keld ;
Hoffmann, Torsten .
DRUG DISCOVERY TODAY, 2015, 20 (01) :122-128
[48]  
Frank R, 1996, Methods Mol Biol, V66, P149
[49]   The SPOT synthesis technique - Synthetic peptide arrays on membrane supports - principles and applications [J].
Frank, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 267 (01) :13-26
[50]  
Gaida Annette, 2009, V535, P263, DOI 10.1007/978-1-59745-557-2_16